The Food and Drug Administration yesterday approved the first test to use next generation sequencing technology to detect HIV drug-resistance mutations in patients taking or about to start antiviral therapy. “The right combination of antivirals can lower viral loads, or the amount of virus in the blood stream, and help keep patients with HIV healthy for many years,” said Peter Marks, M.D., director of FDA’s Center for Biologics Evaluation and Research. “However, according to a recent report from the Centers for Disease Control and Prevention and the World Health Organization, the percentage of people living with HIV around the world that have resistance to some HIV drugs has increased from 11% to 29% since 2001.”

Related News Articles

Headline
The AHA, American Medical Association, American Society of Anesthesiologists, American Society of Health-System Pharmacists, and Association for Clinical…
Headline
Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D…
Headline
The Food and Drug Administration today released a proposed rule that would allow states and other non-federal government entities to establish programs to…
Headline
A total of 2,291 patients have been hospitalized for vaping-associated lung injuries in the states, Puerto Rico and U.S. Virgin Islands, and 48 people have…
Headline
Achieving the U.S. goal of reducing new HIV infections by 90% over 10 years will require accelerated efforts to diagnose, treat and prevent HIV, according to a…
Headline
A new Centers for Disease Control and Prevention study published today in JAMA Pediatrics reveals that nearly one in five adolescents aged 12-18 years,…